Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.
Featured Items
New Content
Mount Sinai Kravis Children’s Hospital has appointed Arthur Smerling, MD, a leading expert in pediatric critical care, as Chief of the Division of Pediatric Critical Care Medicine in the Jack and Lucy Clark Department of Pediatrics.
Findings provide insight about its potential as a noninvasive therapy
AI-powered planning and robotic precision revolutionize treatment, preserving continence and sexual function
Join us for our upcoming webinar on Thursday, February 13, 2025 from 1-2pm.
Mount Sinai Study Finds Wearable Devices Can Detect and Predict Inflammatory Bowel Disease Flare-Ups
Data collected by wearable technology can identify disease flare-ups up to seven weeks in advance.
Changes in Microbiome Predict Risk for Sexually Transmitted Disease
This study was made possible by the participation of young women of color, who are at highest risk for this infection and most likely to experience its negative impact,” said study co-author Angela Diaz, M.D., Ph.D., MPH
A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center
Mount Sinai Researchers Create AI Tool to Democratize Access to Cancer Immunotherapy
Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK)
Mount Sinai Researchers Move Closer to a Cure for Diabetes
New research confirms a novel route for human beta cell regeneration.
Cancer Immunotherapy at Mount Sinai: Progress Towards Curing the Uncurable
Mount Sinai is moving the bar on immunotherapy to improve outcomes for patients
Mount Sinai Adds a Rehab Component to Its Management of Pulmonary Disease
Mount Sinai Health System recently opened a comprehensive pulmonary rehabilitation program geared to patients with exercise limitations attributable to the lung or other organs. It offers them 8 to 12 weeks of muscle strengthening, helpful ...
Uncovering the Familial Link in Women with Postpartum Psychosis
A large cohort study from Mount Sinai provides evidence, for the first time, on familial risk of postpartum psychosis. The findings pave the way for preventive work that can be done for women at increased risk.
Exploring Links Between ‘Forever Chemicals’ and Thyroid Cancer
A group of per- and polyfluoroalkyl substances (PFAS)—endocrine-disrupting chemicals commonly dubbed "forever chemicals" due to their ability to persist in the environment—has long been thought to contribute to cancer risk. A Mount Sinai ...
As Technology Progresses, Aneurysm Treatments Become Safer and More Reasonable to Consider
Observing the 2.4 mm aneurysm in one female patient seemed reasonable in 2013. But when the evolution of endovascular techniques and technology provided an opportunity to cure her aneurysm in 2024, the 70-year-old patient sought treatment ...
A Combination Treatment, Including Harmine, Can Increase Human Insulin-Producing Cells in Vivo
Mount Sinai researchers have demonstrated that a two-drug combination to enable the regeneration of insulin-producing pancreatic beta cells for people with diabetes. One of the drugs, harmine, is a natural product found in plants.
The new clinical trial, led by Valentín Fuster, MD, PhD, is responding to clinical evidence that the atherosclerotic process starts early in life, and even in young adults deemed otherwise healthy can pave the way for cardiovascular events.
Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society
President of Mount Sinai Fuster Heart Hospital given top honor for his contributions to the understanding and treatment of atherosclerosis.